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Summary statement. Physiological analyses suggest that mice lacking urea transporters have increased renal purinergic signaling, perhaps contributing to previously observed vasopressinresistant polyurias.
Introduction
A hypertonic inner medulla is necessary for concentrating urine during antidiuresis, and urea is essential to this mechanism (Sands et al., 2011) . Along with sodium and chloride, urea is a major contributor to the increased osmolality of the inner medullary interstitium (Sands and Layton, 2009) . High interstitial osmolality is sustained by urea reabsorption in the inner medullary collecting duct (IMCD), which in turn drives water reabsorption through the aquaporin channel AQP2 (Klein et al., 2010; Pannabecker et al., 2008; Sands and Layton, 2009 ).
While urea is freely membrane permeable and, with sufficient time, will equalize across a lipid bilayer, maintenance of a hypertonic inner medulla requires rapid urea reabsorption in the IMCD (Sands, 2003) . This is facilitated by the urea transport proteins UT-A1 and UT-A3 (Klein et al., 2011) .
Arginine vasopressin (AVP) is the chief regulator of water reabsorption in the collecting duct. Antidiuresis is initiated by AVP binding to the G protein-coupled receptor vasopressin receptor 2 (V2R), which leads to increased intracellular levels of cAMP (Rieg et al., 2010; Vallon and Rieg, 2011) . Elevated cAMP levels promote phosphorylation of UT-A1 and AQP2, increasing UT-A1-mediated urea reabsorption, and thereby AQP2-mediated water entry (Blount et al., 2008; Hoffert et al., 2006) . In the presence of a transepithelial osmolality gradient, AVP induces IMCD cell swelling (Chou et al., 2008; Ganote et al., 1968) , which releases local factors such as the purine nucleotide adenoside-5'-triphosphate (ATP), augmenting the AVP response (Vallon and Rieg, 2011) .
Renal epithelial cells release ATP in response to multiple stimuli, including increased luminal flow rate and elevated cell volume (Schwiebert, 2001; Vallon and Rieg, 2011) . Once released into the extracellular environment of the inner medulla, ATP acts locally on membrane-bound P2 purinergic receptors. Several receptor subtypesincluding both ionotropic P2X receptors and metabotropic P2Y receptorsare localized to the rat collecting duct (Wildman et al., 2009) . In humans, of the seven known P2X receptor subunits, only P2X4 has been detected in significant amounts in the collecting duct (Chabardes-Garonne et al., 2003) . Studies have shown that broad activation of P2X receptors increases water excretion; however, these effects were largely attributed to the proximal tubule (Jankowski et al., 2011) . Although evidence suggests that P2X receptors are important to various aspects of renal physiology, the specific role P2X receptors play in the IMCD has not yet been elucidated (Burnstock et al., 2014; .
Several studies have demonstrated that extracellular purines modulate water handling in the IMCD through P2Y receptors (Boone and Deen, 2008; Burnstock et al., 2014) . These Gprotein-coupled receptors are subdivided based on the targets of their associated G-protein subunits; of the eight P2Y receptors identified, P2Y1, P2Y2, P2Y4, P2Y6, and P2Y11 stimulate phospholipase C through the G-protein Gαq (Erb et al., 2006; Vallon and Rieg, 2011) . Although many P2Y receptors have been reported in renal epithelia and cultured cell lines of renal origin, the P2Y2 subtype is apparently the most predominant P2Y receptor expressed in native collecting duct tissue (Insel et al., 2001; Kishore et al., 2000; Schwiebert and Kishore, 2001; Turner et al., 2003) .
Following the identification of the receptor's location in the collecting duct, studies revealed that ATP-driven P2Y2 receptor activation is an important regulator of water reabsorption (Ecelbarger et al., 1994; Edwards, 2002; Kishore et al., 1995; Rouse et al., 1994; Sun et al., 2005a; Vallon and Rieg, 2011) . As discussed above, elevated cAMP levels promote AQP2-mediated water entry, increasing cell volume (Blount et al., 2008; Hoffert et al., 2006) . Increases in cell volume lead to the release of ATP at both the basolateral and apical sides of the IMCD (Hovater et al., 2008) , and subsequent ATP driven P2Y2 receptor activation inhibits AVPmediated water permeability via phospholipase C inhibition of cAMP, thereby normalizing cell volume and accelerating the excretion of free water (Ecelbarger et al., 1994; Edwards, 2002; Kishore et al., 1995; Rouse et al., 1994; Sun et al., 2005a; Vallon and Rieg, 2011) . Experiments in isolated IMCD indicate that ATP can stimulate the release of prostaglandin E2 (PGE2) by activation of P2Y2 receptors (Sun et al., 2005a; Welch et al., 2003) . PGE2 is known to affect the transport of water and urea in the IMCD (Rouch and Kudo, 2000) , presumably through interactions of a purinergic system, by tonically inhibiting the stimulating effect of AVP in the renal medulla.
While not fully understood, evidence does suggest that urea transport in the IMCD is regulated through purinergic signaling. In mice lacking P2Y2 receptors, urea transporter expression is elevated, which likely contributes to the observed increased urinary concentration capacity of these animals (Zhang et al., 2008) . Furthermore, in animals with elevated inner medullary purinergic signaling, UT-A1 protein abundance is reduced (Blount et al., 2010; Zhang et al., 2009) , and functional data demonstrate that urea transport can be modulated by PGE2 post-cAMP-dependent events (Rouch and Kudo, 2000) . However, how urea transport might affect the purinergic-prostanoid system remains to be fully elucidated. In this study, we aimed to elucidate the importance of urea transport to purinergic signaling in the IMCD using transgenic mice lacking UT-A1 and UT-A3. We show that, in the absence of UT-A1 and UT-A3, there are unexpectedly low levels of luminal cAMP, despite elevated vasopressin levels. Levels of ATP, PGE2, and P2Y2 protein expression in the IMCD are increased, collectively suggesting an increase in purinergic receptor activation in the absence of urea transport.
Materials and Methods

Animals
All animal protocols were approved by the Emory University Institutional Animal Care and Use Committee. All studies were performed using male mice between 8-10 weeks of age that either (1) did not express UT-A1 or UT-A3 (UT-A1/A3 -/-; UT-A1/A3 KO) or (2) were control, wildtype littermates (UT-A1/A3 +/+ ; WT). UT-A1/A3 KO mice were a generous gift from Dr. Jeff M.
Sands (Emory University, Atlanta, GA) who regenerated the line on a C56BL/6J background from the original NIH source, as previously described (Fenton et al., 2004; Ilori et al., 2013) .
Mice were individually housed in Tecniplast Single Metabolic Cages (Tecniplast USA Inc, Exton, PA) for 24 hours of acclimation, followed by 24 hours of urine collection and food/fluid intake measurements.
Analysis of urine and serum samples
Urine osmolality was measured using a Wescor 5520 Vapor Pressure Osmometer (Wescore, Logan, UT). Urine creatinine was measured by the Jaffe reaction with a colorimetric kit (BioVision, Inc., Milpitas, CA). Urinary levels of cAMP, ATP and prostaglandin were measured using a Cyclic AMP EIA kit (Caymen Chemical, Ann Arbor, MI), a Prostaglandin E2 Express EIA kit (Caymen Chemical, Ann Arbor, MI), and a colorimetric ATP assay kit (BioVision, Inc., Milpitas, CA), respectively. Serum vasopressin levels were measured using an Arg 8 -Vasopressin ELISA Kit (Enzo Life Sciences,). All assay kits were used according to manufacturer specifications.
Western blot analysis
Whole kidneys were collected, dissected into inner medulla (IM) and outer medulla (OM), and lysates prepared using an SDS lysis buffer. Protein content was quantified using the Bio-Rad DC Protein Assay Kit (Bio-Rad Laboratories, Hercules, CA). Proteins (20 µg/lane) were resolved on 12.5% SDS-PAGE gels and then electroblotted to polyvinylidene difluoride (PVDF) membranes (Millipore, Bedford, MA). After blotting, membranes were blocked for 1 hour in Odyssey Blocking Buffer (Li-COR, Lincoln, NE) and then probed overnight at 4ºC with a primary antibody specific against UT-A1 (1:1000; previously characterized (Naruse et al., 1997)), UT-A3 (1:100; previously characterized (Blount et al., 2007) ), AQP2 (1:2000; StressMarq, Victoria, BC, Canada), or P2Y2 , (1:200; Alomone Labs, Jerusalem, Israel).
Membranes were washed in TBS-tween solution, then probed with Alexa680-conjugated antirabbit secondary antibody (1:4000; Life Technologies, Grand Island, NY). Probed membranes were again washed, and then visualized using infrared detection via the LI-COR Odyssey protein analysis system. To ensure equal loading and to quantify densitometric scanning, membranes were stained with coomassie blue to visualize total protein load. All densitometries were collected using ImageJ software (National Institutes of Health, Bethesda, MD).
Immunofluroescence
Tissues were prepared as described previously (Sim et al., 2014) . Whole kidney sections were hydrated with ethanol, and endogenous peroxides were quenched with 3% H2O2. After antigen retrieval using TEG buffer and quenching free aldehyde groups with 50 mM NH4Cl/PBS, sections were blocked in 1% BSA/PBS for 30 min at room temperature. Sections were incubated overnight at 4ºC with an antibody specific to AQP2 (1:300, Santa Cruz Biotechnology, Dallas, Texas). After several PBS washes, sections were incubated for 2 hours at room temperature with 
Statistical analysis
Data are expressed as the mean ± standard error of the mean, and n is the number of animals.
Differences were determined by Student's t-test using GraphPad Instat Software (La Jolla, CA). P values <0.05 were considered statistically significant.
Results
UT-A1/A3 KO mice are polyuric and have a reduced ability to reabsorb urea.
Western blot analysis of inner medullary tissues collected from the UT-A1/A3 null strain developed by Ilori et al. confirms that UT-A1/A3 KO mice do not express either UT-A1 or UT-A3 proteins (Fig. 1a) (Ilori et al., 2013) . Inner medullary AQP2 protein expression was unaffected by the loss of urea transporters under basal conditions (Fig. 1b) , and immunofluorescence tagging confirms that AQP2 was present at the apical membrane of IMCD cells in both WT and UT-A1/A3 KO animals ( Fig. 2 ).
Compared to WT mice, UT-A1/A3 KO mice had an elevated 24-hour urine volume ( Fig.   3a ) and a much lower urine osmolality (Fig. 3b ), demonstrating that they were polyuric. When corrected for urine dilution, urinary urea concentrations were roughly 7.5-fold higher in UT-A1/A3 KO mice compared to WT animals (Fig. 3c) , demonstrating a decreased ability to reabsorb urea in the absence of UT-A1 and UT-A3. This metabolic characterization of UT-A1/A3 KO mice confirms previous reports establishing the importance of UT-1 and UT-A3 in urine concentration (Fenton et al., 2004; Ilori et al., 2013) .
UT-A1/A3 KO mice have low urinary cAMP excretion despite elevated AVP levels.
Serum analysis indicated that circulating AVP levels were significantly elevated in UT-A1/A3 KO mice (Fig. 4a ). As previously discussed, AVP activates V2R, increasing intracellular cAMP levels (Hoffert et al., 2006; Pearce et al., 2014) . With this mechanism in mind, we investigated urinary levels of cAMP. Interestingly, urinary cAMP levels were significantly lower in UT-A1/A3 KO mice as compared to WT animals, despite elevated AVP levels (Fig. 4b) .
AVP-mediated water reabsorption is inhibited by ATP-mediated activation of P2Y2, thereby dampening cAMP synthesis (Kishore et al., 1995) . Given the decreased urinary cAMP levels observed in UT-A1/A3 KO mice, we suspected that there was an increase in ATPmediated P2Y2 activation. Analysis confirms that urinary ATP levels were higher in UT-A1/A3 KO mice as compared to WT mice (Fig. 4c ).
This elevation in urinary ATP led us to speculate that, similar to other animal models of AVP-resistant polyuria (Sun et al., 2005a) , purinergic signaling was increased in the UT-A1/A3 KO mice. Although the IMCD releases moderate amounts of PGE2 under basal conditions, specific activation of the P2Y2 receptor results in an enhanced release of PGE2 from IMCD cells in a time-and concentration-dependent manner (Welch et al., 2003) . Therefore, to indirectly analyze the ATP-activation of the P2Y2 receptor in the IMCD, we measured urinary excretion of PGE2. Immunoassays revealed that PGE2 levels were higher in UT-A1/A3 KO mice as compared to WT mice (Fig. 4d ).
UT-A1/A3 KO mice have elevated P2Y2 protein expression in the inner medulla.
P2Y2 activation in response to ATP release in the collecting duct is critical for modulating water transport (Vallon et al., 2012) . To determine if an increase in P2Y2 receptor abundance contributed to the observed increase in purinergic activity in UT-A1/A3 KO mice, we first measured P2Y2 mRNA expression in the medullary tissues of these animals using quantitative real-time RT-PCR ( Fig 5) . There was no significant difference in P2Y2 mRNA expression in the medullary tissues of WT and UT-A1/A3 KO mice ( Fig 5) .
Others investigating the expression profiles of P2Y2 in rodent IMCD found that mRNA and protein levels of the receptor can be discordant (Kishore et al., 2005) . Because of these observations, we measured P2Y2 protein abundance in the inner and outer medullary tissues of these animals.
Corroborating previous reports, we observed P2Y2 protein in both medullary tissues ( Fig.   6 ) (Kishore et al., 2000) . P2Y2 was more abundant in the inner medulla of UT-A1/A3 KO mice as compared to WT (Fig. 6) , indicating that an increase in receptor abundance may be contributing to the observed increase in purinergic activity.
Discussion
Many have shown that local factors, including ATP, may modulate the actions of AVP (Pearce et al., 2014). In the IMCD, ATP activates P2Y2 receptor, thereby inhibiting AVP-mediated water permeability via phospholipase C inhibition of cAMP. The activation of the P2Y2 receptor ultimately leads to PGE2 release (Sun et al., 2005a; Welch et al., 2003) . ATP modulation of AVP-stimulated water transport in the IMCD has been studied extensively employing both pharmacological approaches (Ecelbarger et al., 1994; Kishore et al., 1995; Sun et al., 2005a; Sun et al., 2005b) , and metabolic examination of mice lacking P2Y2 receptors (Rieg et al., 2007; Zhang et al., 2008) ; however, the role that urea transport plays in the purinergic-prostanoid system has not been extensively studied.
In the studies described herein, we found that mice simultaneously lacking both the apical urea transporter, UT-A1, and the basolateral urea transporter, UT-A3, have extensive polyuria despite unchanged levels of AQP2 expression and elevated circulating AVP. We observed lower levels of urinary cAMP in UT-A1/A3 KO mice as compared to wild-type litter mates.
Furthermore, we observed that UT-A1/A3 KO mice have increased urinary PGE2 levels as compared to wild-type litter mates, as well as elevated expression of the P2Y2 receptor in inner medullary tissues. These data collectively indicate an increase in P2Y2 activity in UT-A1/A3 KO mice. Two aspects of IMCD physiology appear to be contributing to this observed change: 1) an increase in P2Y2 receptor protein abundance, and 2) the increase of the P2Y2 agonist ATP.
An increase in P2Y2 protein abundance, given suitable agonist levels, might lead to an increase in total P2Y2 activity; we observed, via western blot, an increase in total P2Y2 protein in the inner medulla. Previous studies have linked UT-A1 and P2Y2 abundance in a backwards fashion, demonstrating that in the absence of P2Y2, UT-A1 protein abundance is increased (Zhang et al., 2008) . Additionally, in models of heightened purinergic activity, UT-A1 protein abundance is reduced (Blount et al., 2010; Zhang et al., 2009) . Our data, in conjunction with previous data, indicates some sort of co-regulatory function between these proteins. Future studies are needed to clarify this relationship between the urea transporters and P2Y2 in the IMCD.
Although P2Y2 appears to regulate urea transporter abundance, it is unclear what mechanism is at play by which the absence of UT-A1 and UT-A3 stimulates P2Y2 protein synthesis. A likely explanation is that in the absence of urea transport in the IMCD, medullary tonicity is decreased, resulting in enhanced P2Y2 abundance. In vivo studies suggest that alterations in P2Y2 abundance are regulated by medullary tonicity (Kishore et al., 2005) , which was later supported by in vitro studies in mpkCCD cells (Wildman et al., 2009) . In fact, inner medullary tissue osmolality is significantly higher in mice lacking P2Y2 receptors, suggesting that the elevated UT-A1 abundance observed in these same mice increases their urea recycling capability (Zhang et al., 2013; Zhang et al., 2008) .
Interestingly, we observed a discrepancy between P2Y2 protein abundance and mRNA expression, but discrepancies of this sort have been previously reported (Insel et al., 2001; Kishore et al., 2005) . It is not uncommon for G protein-coupled receptors like P2Y2 to be sequestered into the cytoplasm to either be recycled back to the plasma membrane, or sorted for degradation into lysosomes. Biochemical studies examining the cellular trafficking of a tagged-P2Y2 demonstrate that the receptor can be internalized by a clathrin-mediated pathway and degraded through a proteasome pathway (Sromek and Harden, 1998; Tulapurkar et al., 2005) .
Increased AVP levels induce a cAMP-dependent translocation of P2Y2 receptors into the basolateral membrane (Wildman et al., 2009) suggesting that the observed receptor recycling and possibly degradation may be mediated by AVP. This and other possible explanations will need to be explored in more extensive investigations to elucidate the reason for the observed difference; other explanations may involve posttranslational modification, or other aspects of P2Y2 protein stability and turnover.
Increased levels of ATP might also drive increased P2Y2 activation, and we observed an increase of urinary ATP in UT-A1/A3 KO mice. As previously discussed, rapid changes to the tonicity of the inner medullary interstitium is responsible for increased IMCD cell size, and the subsequent release of ATP is essential to normalizing cell volume by driving P2Y2 activation.
Previous studies indicate that acute water loading increases the release of ATP due to the reduction of extracellular tonicity and a resultant increase in cell volume (Rieg et al., 2007) . It has been previously demonstrated, and we have confirmed, that UT-A1/A3 KO mice have a reduced ability to reabsorb urea, and thus have higher levels of urinary urea when compared to wild type animals. Given that urea is a major osmotic player, its presence in luminal fluid could be building osmotic potential toward the lumen of the collecting duct. Water moving from the interstitium toward the collecting duct, through the basolateral aquaporins AQP3 and AQP4, could increase cell volume, releasing ATP at both the basolateral and apical membranes, contributing to the observed increase in ATP, and ultimately to an increase in P2Y2 activation.
Among previously mentioned stimulators, increased luminal flow increases luminal ATP expression in principal cells of the collecting duct (Jensen et al., 2007; Praetorius and Leipziger, 2010) . UT-A1/A3 KO mice are polyuric, and as such, luminal flow rates in the collecting duct are likely increased as compared to wild-type mice. It is worth noting, however, that urinary flow rate alone is not a good predictor of urinary ATP excretion (Rieg and Vallon, 2009) . At this time, it is unclear what other factors may be involved.
We observed that AQP2 protein abundance remains unchanged in UT-A1/A3 KO mice, and as such the potential for water movement is likely unaffected. Granted that urea recycling in the inner medulla is ablated in the UT-A1/A3 KO mice, there are no reported differences in the expression of sodium transporters in the distal nephron and collecting ducts of these animals (Fenton et al., 2005) , suggesting that sodium reabsorption can still contribute to generating a weakened osmotic gradient in the medullary interstitium. However, because of possible elevated purinergic-prostanoid activity in the UT-A1/A3 KO mice, we predict that any possible water reabsorption by AQP2 would be inhibited despite the presence of a dampened osmotic gradient.
Therefore, the polyuria seen in the UT-A1/A3 KO mice is likely compounded by the inability of these mice to reabsorb luminal water in the IMCD.
While many studies agree that PGE2 plays an important role in regulating water excretion by modulating the effects of AVP, PGE2-diuretic effects are extremely variable. For instance, PGE2 stimulates water transport in the absence of AVP, but decreases water and urea permeability in the presence of AVP (Hebert et al., 1993; Rouch and Kudo, 2000) . Although the understanding of the underlying molecular mechanisms behind the PGE2-mediated inhibition of urea and water transport remains incomplete, the differences in PGE2-mediated actions are likely explained by the diverse range of biologic actions elicited by the four E-prostanoid receptor subtypes, EP1, EP2, EP3, and EP4 (Breyer and Breyer, 2001; Olesen and Fenton, 2013) . While not investigated herein, we speculate that the elevated PGE2 levels observed in UT-A1/A3 KO mice may inhibit AVP-induced water reabsorption through the EP3 receptor. EP3 receptor stimulation, which is coupled to Gi, would explain the decrease levels of urinary cAMP in these mice despite elevated AVP. EP3-deficient mice can concentrate urine similar to WT mice after both water loading and water deprivation; however, pharmacological inhibition of PGE2 production only increases urine osmolality in WT mice. These studies suggest that PGE2 action through the EP3 receptor is not essential for urine concentration under normal conditions, but when PGE2 is elevated, as observed in the UT-A1/A3 KO mice, the EP3 receptor likely plays a crucial role (Fleming et al., 1998) . Further support comes from a recent study demonstrating that lithium-induced polyuria is attenuated in P2Y2 KO mice (Zhang et al., 2013) . EP3 receptor expression is downregulated in the collecting ducts of lithium-treated P2Y2 KO mice, and PGE2stimulation of isolated IMCD tubules from these mice stimulates cAMP production at higher rates than lithium-treated WT mice. Not only do these findings suggest that the IMCD can become more sensitive to PGE2 in response to altered physiological settings like elevated urine flow, but these studies also demonstrate that P2Y2 is a prominent regulator of EP3 abundance.
In conclusion, using UT-A1/A3 KO mice we have demonstrated that urea transport in the inner medulla is modulated in some part by the purinergic-prostanoid system. Although most previous studies have focused on local regulation of water reabsorption in the IMCD by ATP, the effect of this nucleotide on urea handling in the inner medulla is largely unknown. This work represents the first step in understanding the connection between P2Y2-regulation of the urea transporters UT-A1 and UT-A3. 
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